Heinrich Walt

Prof. Dr. Heinrich Walt


Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2011 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
EGEmina Besic Gyenge
Emina Besic Gyenge
XDXenia Darphin
Xenia Darphin
AWAmina Wirth
Amina Wirth
UPUwe Pieles
Uwe Pieles
HWHeinrich Walt
Heinrich Walt
CMCaroline Maake
Caroline Maake
Head and neck squamous cell carcinoma (HNSCC) is currently the eighth leading cause of cancer death worldwide. The often severe side effects, functional impairments and unfavorable cosmetic outcome of conventional therapies for HNSCC have prompted the quest for novel treatment strategies, including the evaluation of nanotechnology to improve e.g. drug delivery and cancer imaging. Although silica nanoparticles hold great promise for biomedical applications, they have not yet been investigated in the context of HNSCC. In the present in-vitro study we thus analyzed the cytotoxicity, uptake and intracellular fate of 200-300 nm core-shell silica nanoparticles encapsulating fluorescent dye tris(bipyridine)ruthenium(II) dichloride with hydroxyl-, aminopropyl- or PEGylated surface modifications (Ru@SiO2-OH, Ru@SiO2-NH2, Ru@SiO2-PEG) in the human HNSCC cell line UMB-SCC 745.

3 October 2016 in Journal of Nanobiotechnology
Verified
Journal Article
Open access
PDF file
DHDoris Hinger
Doris Hinger
SGSusanna Gräfe
Susanna Gräfe
FNFabrice Navarro
Fabrice Navarro
Bernhard SpinglerBernhard Spingler
Bernhard Spingler
DPDevaraj Pandiarajan
Devaraj Pandiarajan
CMCaroline Maake
Caroline Maake
Photodynamic therapy (PDT) as promising alternative to conventional cancer treatments works by irradiation of a photosensitizer (PS) with light, which creates reactive oxygen species and singlet oxygen (1O2), that damage the tumor. However, a routine use is hindered by the PS’s poor water solubility and extended cutaneous photosensitivity of patients after treatment. In our study we sought to overcome these limitations by encapsulation of the PS m-tetrahydroxyphenylchlorin (mTHPC) into a biocompatible nanoemulsion (Lipidots). In CAL-33 tumor bearing nude mice we compared the Lipidots to the existing liposomal mTHPC nanoformulation Foslip and the approved mTHPC formulation Foscan. We established biodistribution profiles via fluorescence measurements in vivo and high performance liquid chromatography (HPLC) analysis. All formulations accumulated in the tumors and we could determine the optimum treatment time point for each substance (8 h for mTHPC, 24 h for Foslip and 72 h for the Lipidots). We used two different light doses (10 and 20 J/cm2) and evaluated immediate PDT effects 48 h after treatment and long term effects 14 days later. We also analyzed tumors by histological analysis and performing reverse transcription real-time PCR with RNA extracts. Concerning tumor destruction Foslip was superior to Lipidots and Foscan while with regard to tolerance and side effects Lipidots were giving the best results. We could demonstrate in our study that nanoformulations are superior to the free PS mTHPC. The development of a potent nanoformulation is of major importance because the free PS is related to several issues such as poor bioavailability, solubility and increased photosensibility of patients. We could show in this study that Foslip is very potent in destroying the tumors itself. However, because the Lipidots' biocompatibility is outstanding and superior to the liposomes we plan to carry out further investigations and protocol optimization. Both nanoformulations show great potential to revolutionize PDT in the future.

8 January 2023 in Antibiotics
Verified
Journal Article
Open access
PDF file
JPJulia Prinz
Julia Prinz
MWMarianne Wink
Marianne Wink
SNSonja Neuhaus
Sonja Neuhaus
MGMarkus C. Grob
Markus C. Grob
HWHeinrich Walt
Heinrich Walt
YAYvonne Achermann
Yvonne Achermann
Periprosthetic joint infections (PJI) are difficult to treat due to biofilm formation on implant surfaces, often requiring removal or exchange of prostheses along with long-lasting antibiotic treatment. This in vitro study investigated the effect of methylene blue photodynamic therapy (MB-PDT) on PJI-causing biofilms on different implant materials. MB-PDT (664 nm LED, 15 J/cm2) was tested on different Staphylococcus aureus, Staphylococcus epidermidis, Escherichia coli and Cutibacterium acnes strains in both planktonic form and grown in early and mature biofilms on prosthetic materials (polyethylene, titanium alloys, cobalt–chrome-based alloys, and bone cement). The minimum bactericidal concentration with 100% killing (MBC100%) was determined. Chemical and topographical alterations were investigated on the prosthesis surfaces after MB-PDT. Results showed a MBC100% of 0.5–5 μg/mL for planktonic bacteria and 50–100 μg/mL for bacteria in biofilms—independent of the tested strain, the orthopedic material, or the maturity of the biofilm. Material testing showed no relevant surface modification. MB-PDT effectively eradicated common PJI pathogens on arthroplasty materials without damage to the materials, suggesting that MB-PDT could be used as a novel treatment method, replacing current, more invasive approaches and potentially shortening the antibiotic treatment in PJI. This would improve quality of life and reduce morbidity, mortality, and high health-care costs.

25 October 2005 in British Journal of Cancer
Verified
Journal Article
Open access
ADA M Dorward
A M Dorward
KFK S Fancher
K S Fancher
TDT M Duffy
T M Duffy
WBW G Beamer
W G Beamer
HWHeinrich Walt
Heinrich Walt
A photodynamic technique for human breast cancer detection founded upon the ability of tumour cells to rapidly accumulate the fluorescent product protoporphyrin IX (PpIX) has been applied to transgenic mouse models of mammary tumorigenesis. A major goal of this investigation was to determine whether mouse mammary tumours are reliable models of human disease in terms of PpIX accumulation, for future mechanistic and therapeutic studies. The haeme substrate 5-aminolevulinic acid (5-ALA) (200 mg kg−1) was administered to mouse strains that develop mammary tumours of various histological subtypes upon expression of the transgenic oncogenes HRAS, Polyoma Virus middle T antigen, or Simian Virus 40 large T antigen in the mammary gland. Early neoplastic lesions, primary tumours and metastases showed consistent and rapid PpIX accumulation compared to the normal surrounding tissues, as evidenced by red fluorescence (635 nm) when the tumours were directly illuminated with blue light (380–440 nm). Detection of mouse mammary tumours at the stage of ductal carcinoma in situ by red fluorescence emissions suggests that enhanced PpIX synthesis is a good marker for early tumorigenic processes in the mammary gland. We propose the mouse models provide an ideal experimental system for further investigation of the early diagnostic and therapeutic potential of 5-ALA-stimulated PpIX accumulation in human breast cancer patients.

30 October 2018 in Information
Verified
Journal Article
Open access
PDF file
VKVanessa Klaas
Vanessa Klaas
GTGerhard Tröster
Gerhard Tröster
HWHeinrich Walt
Heinrich Walt
JJJosef Jenewein
Josef Jenewein
Cancer related fatigue is a chronic disease that may persist up to 10 years after successful cancer treatment and is one of the most prevalent problems in cancer survivors. Cancer related fatigue is a complex symptom that is not yet explained completely and there are only a few remedies with proven evidence. Patients do not necessarily follow a treatment plan with regular follow ups. As a consequence, physicians lack of knowledge how their patients are coping with their fatigue in daily life. To overcome this knowledge gap, we developed a smartphone-based monitoring system. A developed Android app provides activity data from smartphone sensors and applies experience based sampling to collect the patients’ subjective perceptions of their fatigue and interference of fatigue with the patients’ daily life. To evaluate the monitoring system in an observational study, we recruited seven patients suffering from cancer related fatigue and tracked them over two to three weeks. We collected around 2700 h of activity data and over 500 completed questionnaires. We analysed the average completion of answering the digital questionnaires and the wearing time of the smartphone. A within-subject analysis of the perceived fatigue, its interference and measured physical activity yielded in patient specific fatigue and activity patterns depending on the time of day. Physical activity level correlated stronger with the interference of fatigue than with the fatigue itself and the variance of the acceleration correlates stronger than absolute activity values. With this work, we provide a monitoring system used for cancer related fatigue. We show with an observational study that the monitoring system is accepted by our study cohort and that it provides additional details about the perceived fatigue and physical activity to a weekly paper-based questionnaire.

8 April 2025 in Microorganisms
Verified
Journal Article
Open access
PDF file
KLK L
K L
GKGabor Kadler
Gabor Kadler
AKAlexander Kalyanov
Alexander Kalyanov
TSTiziano Angelo Schweizer
Tiziano Angelo Schweizer
HWHeinrich Walt
Heinrich Walt
HEHarald Essig
Harald Essig
In patients with predisposing risk factors, bacterial colonization of dental implants can lead to periimplantitis (PI). Established individual treatment protocols can be effective, but antimicrobial resistance (AMR) and biofilm formation may impede successful treatment, therefore requiring surgical intervention. Photodynamic Inactivation (PDI) combined with optical waveguides could eradicate such pathogens without the risk of new AMR emergence and reduce the need for surgery. In this pilot study, we investigated the waveguiding function of light-transmitting zirconium dioxide (ZrO2) dental implants of different diameters by quantifying their transmission spectrum, fraction of transmitted red-light intensity, and potential polarizing properties. In addition, PDI experiments involving in vitro grown Staphylococcus epidermidis biofilms on ZrO2 and titanium alloy (TAV) discs were performed. Colonized discs were treated with Methylene Blue (MB) photosensitizer before red-light illumination (670 nm) at various intensities. A reduction in bacterial colony-forming units (CFUs) of up to 85% was observed on ZrO2 discs. Meanwhile, the biofilms grown on TAV discs showed no significant reduction in CFUs. These findings make ZrO2 a potential candidate in augmentative PDI treatment of PI. The successful use of PDI combined with waveguiding ZrO2 dental implants can support the reduction in antibiotic prescriptions, thus advancing the WHO’s One Health approach of antibiotic stewardship.